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L
isteria monocytogenes is a facultative intracellular bacterium that causes foodborne disease in humans. In mouse models of listeriosis, orally transmitted L. monocytogenes establishes infection in the gut and then spreads systemically to the spleen, liver, and gallbladder (1, 2) . Susceptibility to listeriosis varies among inbred mouse strains; for example, compared to what is seen in C57BL/6 (B6) or C57BL/10 mice, bacterial burdens rise to significantly higher levels and clearance is delayed in BALB/c mice (2) (3) (4) . This difference has been attributed primarily to facets of innate immunity, including differential expression of STAT4 and reduced or delayed secretion of tumor necrosis factor alpha (TNF-␣), interleukin-12 (IL-12), and gamma interferon (IFN-␥) (5) (6) (7) (8) .
One mechanism for innate clearance of L. monocytogenes is direct killing by neutrophils (polymorphonuclear leukocytes [PMN] ). Early work to deplete PMN from mice relied on an antibody (clone RB6-8C5) that was subsequently shown to bind both PMN and monocytes (9) (10) (11) (12) (13) . More recent depletion strategies designed to avoid this issue yielded conflicting results about the importance of PMN for clearance from the liver (14, 15) . PMN in the liver were found either to kill bacteria released from apoptotic hepatocytes or perhaps to directly lyse infected hepatocytes, releasing the bacteria from a protective niche (16) (17) (18) . Despite PMN recruitment to the liver, CFU burdens in BALB/c mice increased steadily for approximately 5 days; in contrast, exponential growth of L. monocytogenes was restricted in B6 livers and the number of CFU began to fall after approximately 3 days (2, 3) . This suggests that BALB/c PMN might be less efficient at killing L. monocytogenes than B6 PMN.
PMN make up the majority of immune cells in human blood but account for only about 15% of circulating immune cells in the mouse (19, 20) . Since human blood is readily available in larger quantities than murine blood, human PMN are most commonly used for in vitro assays that study interactions of PMN with bacteria. Murine PMN lack defensins and have a low affinity for the prototypical formylated peptide formylmethionyl-leucyl phenylalanine (fMLF), but they do possess a strong affinity for formylated peptides derived from L. monocytogenes and Staphylococcus aureus (21) (22) (23) . Differences in relative speed and migration distance have also been noted when murine and human PMN were compared in chemotaxis assays (24) . The difficulty in obtaining large numbers of PMN from mice and the potential for functional differences with human cells have resulted in a lack of studies using murine PMN. However, PMN isolated from human peripheral blood cannot be used to evaluate how PMN contribute to susceptibility or resistance in mouse models of infection.
It has been estimated that mature PMN remain in the bone marrow of mice for up to 2 days before being released into circulation (25) . Boxio et al. first showed that mouse bone marrow is an abundant source of morphologically mature PMN and that these cells release both primary and secondary granules upon stimulation (26) . Swamydas and Lionakis further refined the enrichment protocol and showed that PMN harvested from bone marrow could be used for adoptive transfer (27) . In this study, we used PMN enriched from the bone marrow of naive or infected BALB/c and B6 mice and compared the abilities of the cells to kill L. monocytogenes directly ex vivo. We demonstrate that murine neutrophils efficiently kill serum-opsonized L. monocytogenes using both oxidative and nonoxidative mechanisms. We concluded that there were no intrinsic differences in the capacity of PMN from susceptible BALB/c and resistant B6 mice to directly kill L. monocytogenes.
RESULTS
Hepatic PMN infiltration after foodborne infection is similar in BALB/c and B6 mice. Using the foodborne model of listeriosis in mice, L. monocytogenes colonizes the gut tissue for 24 to 48 h and then spreads systemically to the spleen and liver (2, 28) . Differences in host susceptibility to infection can readily be observed in the liver, where the number of CFU in susceptible BALB/c mice is significantly greater than in the more resistant B6 mice (Fig. 1A) (2) . Neutrophil-rich hepatic abscesses containing L. monocytogenes were observed in both BALB/c and B6 mice 24 h after intravenous infection (29) . To verify that PMN were recruited to the liver parenchyma after foodborne infection, livers were harvested after portal vein perfusion to remove blood, and Ly6G hi FIG 1 Neutrophil recruitment to the liver following foodborne infection is similar in B6 and BALB/c mice. (A) Mice were fed 3 ϫ 10 8 CFU of L. monocytogenes SD2000. At 3 dpi, livers were perfused and total CFU was determined. The total number of Ly6G hi Ly6C ϩ PMN found in the nonparenchymal fraction after tissue digestion in uninfected (NI) or infected (3 d) mice was also determined. Pooled results from three independent experiments are shown. (B) Migration of gradient-enriched PMN toward 100 nM leukotriene B4 was monitored using an under-agarose assay. Representative results from one of three independent experiments are shown (n ϭ 4 technical replicates per group). cells were identified by flow cytometry. At 3 days postinfection (dpi), there was a 5-to 10-fold increase in the number of PMN in the liver, with no significant difference observed between BALB/c and B6 mice (Fig. 1A) . Thus, a lack of PMN infiltration did not explain the greater CFU burden in the BALB/c liver.
After reaching a tissue such as the liver, PMN must further sense and then migrate toward specific chemoattractants, a process that was recently shown to create a "swarm" at infectious foci (30) . To test whether BALB/c cells had a chemotaxis defect, we analyzed the ability of gradient-enriched PMN to migrate toward specific signals using an under-agarose assay. We first tested L. monocytogenes-derived formylated peptides, which were previously shown by Liu et al. to induce chemotaxis from mouse PMN in a Boyden chamber assay (31) . A combination of two formylated peptides (1 M fMIVTLF plus 1 M fMIGWII; Bio-Synthesis, Inc.) did not induce migration in the under-agar assay, despite triggering a burst of intracellular ROS when applied to either BALB/c or B6 PMN (data not shown). However, leukotriene B4, a lipid-derived chemotactic signal produced by PMN (32) , did induce migration of gradient-enriched murine PMN. The maximum distance traveled in 3 h was approximately 900 m for both BALB/c and B6 PMN (Fig. 1B) . Together, these data indicated that recruitment of circulating PMN and chemotaxis toward PMN-derived stimuli was similar in susceptible BALB/c mice and resistant B6 mice.
Unprimed bone marrow neutrophils rapidly kill L. monocytogenes in the presence of autologous serum. Although there was no difference in PMN infiltration, increased bacterial growth in BALB/c mice might also be due to an intrinsic defect in the ability of BALB/c PMN to kill L. monocytogenes. To test this, we developed an in vitro killing assay using PMN isolated from the bone marrow of uninfected mice. PMN were enriched using gradient centrifugation, a method that typically yielded a 65 to 80% pure population of Ly6G hi neutrophils ( Fig. 2A) . The remaining cells were Ly6C hi monocytes (1 to 5%), CD19 ϩ B cells (10 to 20%), and a small number of CD11b ϩ CD64 Ϫ cells (data not shown). The enriched PMN were transferred to a 96-well flat-bottom plate and incubated with L. monocytogenes at a low multiplicity of infection (MOI) for 90 min. As shown in Fig. 2B , there was only a 20% decrease in detectable CFU within this time frame using PMN from either mouse strain. Bortolussi et al. previously showed that L. monocytogenes uptake by human PMN was greatly enhanced when serum was present (33) . To find out if killing efficiency could be improved by exposure to serum proteins, we pretreated late-stationary-phase bacteria with 10% autologous mouse serum for 30 min prior to the addition of PMN. As shown in Fig. 2C , serum pretreatment significantly increased the killing rate within 1 h for both BALB/c and B6 PMN. In contrast, pretreatment with heat-inactivated serum did not enhance killing of L. monocytogenes. Thus, a heat-labile component found in naive serum, most likely complement, contributed significantly to the ability of PMN to kill L. monocytogenes in vitro. Accordingly, serum pretreatment was used for all subsequent killing assays.
In the killing assays described above, the percentage of L. monocytogenes cells killed was calculated by comparing the number of CFU recovered in the presence of PMN to the number of CFU found in assay wells that contained only bacteria. Incubation of L. monocytogenes in tissue culture medium for 1 h resulted in an approximate doubling of the bacteria (Fig. 2D) , a pattern that was consistently observed in all assays. The number of CFU recovered after the addition of gradient-enriched PMN was significantly less than the initial inoculum (Fig. 2D, dashed lines) , demonstrating that the PMN were actively killing bacteria within 1 h rather than simply inhibiting growth. However, given that the PMN outnumbered the bacteria in these assays up to 10-fold, it was surprising that so many viable L. monocytogenes cells remained in each well. To find out if a longer incubation time would allow the PMN to completely clear the inoculum, the killing assay was extended to 4 h. L. monocytogenes incubated in tissue culture medium alone increased more than 30-fold during this time frame (Fig. 2D) . When PMN were added, the number of L. monocytogenes bacteria was 5-fold higher than the initial inoculum, but this number represented an approximate 80% killing rate compared to bacterial growth without PMN. Thus, prolonged incubation time did not increase the efficiency of killing, and extending the incubation period just allowed any bacteria that evaded contact with PMN to replicate exponentially.
Sorted bone marrow PMN maintain viability and killing capacity after in vitro culture. Although gradient centrifugation provided a substantially enriched PMN population to study, it was unknown whether any of the killing observed could be ascribed to the contaminating cells, which typically made up 20 to 35% of the enriched population. To investigate this, three populations of cells were sorted from BALB/c and B6 bone marrow: Ly6G hi Ly6C ϩ PMN, Ly6C hi Ly6G Ϫ monocytes, and the residual Ly6G Ϫ Ly6C Ϫ cells (Fig. 3A) . Each population was plated separately and incubated with L. monocytogenes for 1 h. As shown in Fig. 3B , sorted PMN from both BALB/c and B6 mice The following day, a killing assay was performed as described above. Results from one of two independent experiments with 3 technical replicates per group are shown. killed nearly 80% of the bacteria. Neither monocytes nor the residual population of primarily B cells were capable of killing the bacteria directly ex vivo. These results indicated that murine bone marrow PMN could be sorted without deleterious effects and suggested that the killing observed with gradient-enriched cells was attributable only to the PMN.
To assess the functional ex vivo life span of murine bone marrow PMN, sorted cells were cultured overnight and inoculated with L. monocytogenes the following day. As shown in Fig. 3C , PMN remained capable of killing 60 to 70% of the inoculum after 24 h of in vitro culture. However, in contrast to what was observed directly ex vivo, Ly6C hi monocytes also killed approximately 60% of bacteria. Surprisingly, even the other cells, which were comprised mainly of CD19 ϩ B cells, killed 30 to 40% of L. monocytogenes cells (Fig. 3C) . Therefore, murine PMN are viable and retain efficient killing ability for at least 24 h after isolation from the bone marrow. However, these data indicate that only highly purified sorted PMN should be used for experiments involving cells maintained in culture for more than a few hours.
Bone marrow PMN rapidly internalize and kill L. monocytogenes intracellularly. Human PMN are known to phagocytose particulate matter within seconds, followed by rapid closure of the phagosome, which then fuses with granules containing an array of antibacterial compounds (34) . Extracellular killing mechanisms such as neutrophil extracellular traps have also been described (35) . To assess the importance of bacterial internalization for in vitro killing of L. monocytogenes, sorted PMN were pretreated with cytochalasin D, an inhibitor of actin polymerization. L. monocytogenes bacteria constitutively expressing green fluorescent protein (GFP) were added, and differential "in/ out" staining was performed 10 min later. Nonpermeabilized cells were stained with Texas Red-conjugated polyclonal anti-L. monocytogenes antibodies such that cellassociated extracellular bacteria appeared yellow (Fig. 4A) . Bacteria that were internalized by the PMN, and thus not accessible to the antibodies, appeared green. As shown in Fig. 4A , approximately 90% of the cell-associated L. monocytogenes cells were intracellular 10 min after incubation with either BALB/c or B6 PMN. Pretreatment with cytochalasin D decreased the percentage of intracellular bacteria but did not completely block uptake. Killing assays performed simultaneously also showed a significant reduction in the percentage of bacteria killed when cytochalasin D was used (Fig. 4B) . These results indicated that phagocytosis contributes to the ability of mouse bone marrow PMN to efficiently kill serum-opsonized L. monocytogenes. To investigate the possibility that L. monocytogenes might be efficiently internalized by murine PMN but not killed within the short time period of these assays, a gentamicin protection assay was performed to quantify intracellular bacteria. L. monocytogenes was added to gradient-purified PMN, and gentamicin was added 10 min later. As shown in (Fig. 4C ). These data suggested that a small number of L. monocytogenes cells may be able to avoid killing and survive intracellularly. However, the negligible number of gentamicinresistant bacteria were not likely to influence the percent killed calculations in the in vitro killing assays.
L. monocytogenes induces a respiratory burst in unprimed murine PMN. One of the ways PMN can kill bacteria is though targeted release of reactive oxygen species (ROS). To measure the induction of ROS in PMN exposed to L. monocytogenes, dihydrorhodamine 123 (DHR) fluorescence was used. DHR diffuses across the cell membrane and fluoresces when oxidized to rhodamine by either peroxynitrite, a product of nitric oxide and superoxide, or hypochlorous acid (36) . The short incubation period of the assays described here was not likely to activate inducible nitric oxide synthase (iNOS) (37, 38) ; therefore, in this system, DHR served primarily as a measure of the amount of hypochlorous acid produced by the PMN.
Gradient-enriched PMN from BALB/c and B6 mice were incubated in medium for 1 h and then suspended in buffer prior to the addition of serum-opsonized L. monocytogenes. As shown in Fig. 5A , when the bacteria were added at a low MOI, less than 25% of the PMN produced ROS within 30 min. When 10-fold-more bacteria were added, the number of ROS-positive cells increased significantly for both BALB/c and B6 PMN. Thus, unprimed PMN from both mouse strains rapidly responded to the presence of L. monocytogenes by producing ROS in a dose-responsive manner. Although increasing the MOI resulted in a more robust respiratory burst, the killing efficiency remained at 60 to 80% (Fig. 5B) , as was observed previously for assays using lower MOIs (compare Fig. 5B to Fig. 2C, 3B, and 4B) . Together, these observations suggested that ROS might not be required for efficient killing during the in vitro assay.
Murine PMN use both oxidative and nonoxidative mechanisms to kill L. monocytogenes. To specifically assess the importance of ROS for killing of L. monocytogenes, PMN from gp91 phox -deficient mice were compared to wild-type B6 PMN. The gp91 phoxdeficient mice lack a functional allele for the large gp91 subunit of NADPH oxidase; thus, the enzyme cannot assemble (39) . As shown previously, there was a dosedependent response for wild-type B6 PMN, with an MOI of 10 inducing more ROSpositive cells than even phorbol myristate acetate (PMA) treatment (Fig. 6A) . PMN from gp91 phox -deficient mice produced no detectable ROS at low MOI or after treatment with PMA, but 2 to 5% of the cells became rhodamine positive when L. monocytogenes was added at an MOI of 10. A simultaneous killing assay done with these cells showed that gp91 phoxϪ/Ϫ PMN were as capable of killing L. monocytogenes as cells from the wild-type NADPH oxidase-sufficient mice, regardless of the MOI used (Fig. 6A) . Thus, in genetically deficient mice that were unable to produce ROS from birth, nonoxidative mechanisms were sufficient to kill L. monocytogenes.
As an alternate approach to block ROS activity in both BALB/c and B6 mice, 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (4-hydroxy Tempo [Tempol]) was used to scavenge superoxide produced in response to L. monocytogenes. Tempol is a pleiotropic antioxidant with both superoxide dismutase-and catalase-like properties (40, 41) . Gradient-enriched PMN were pretreated with Tempol for 90 min prior to the addition of L. monocytogenes, and DHR was added to the samples to report the generation of ROS. As shown in Fig. 6B , approximately 20 to 30% of either BALB/c or B6 PMN produced high levels of ROS within 30 min, and pretreatment with Tempol significantly reduced the percentage of ROS hi cells detected. Tempol treatment also resulted in a 10 to 15% reduction in killing by PMN from both mouse strains (Fig. 6B) . These data indicated that in mice genetically capable of producing ROS, scavenging oxidative intermediates (causing less hypochlorous acid to be available) reduced killing efficiency in PMN. However, these data were also consistent with the conclusion that oxidative killing mechanisms are not required to eliminate L. monocytogenes.
Since oxidative mechanisms were not required to kill L. monocytogenes, we hypothesized that inhibition of proteases such as elastase, cathepsin G, and proteinase 3 would result in at least partial loss of killing capacity. To test this, gradient-enriched PMN were incubated with diisopropylfluorophosphate (DFP), a nonspecific serine protease inhibitor. DFP was previously reported to inhibit protease activity without affecting production of ROS (42) . Treatment with 5 mM DFP resulted in a significant reduction in PMN killing ability (Fig. 6C) . However, treatment with 5 mM DFP also completely inhibited the ROS response in PMN exposed to L. monocytogenes. Lowering the concentration to 0.2 mM DFP eliminated the effect on ROS activity, but this concentration did not inhibit bacterial killing (Fig. 6C) . Therefore, it was not possible to determine whether the loss of killing efficiency was due to a loss of serine protease activity or a reduction in ROS availability in wild-type mice. DFP treatment of PMN from gp91 phox -deficient mice, however, did result in a significant loss of killing, suggesting that full protease activity is important for optimal killing in the absence of ROS (Fig. 6D) .
PMN harvested from infected BALB/c and B6 mice kill L. monocytogenes with similar efficiency. Since murine PMN largely stay sequestered in bone marrow until receiving a chemotactic signal to egress into the circulation, the cells used in our in vitro assays were likely to be less activated than cells that are primed to infiltrate infected tissues. To assess the ability of activated cells to kill L. monocytogenes, we harvested bone marrow from BALB/c and B6 mice 2 days after foodborne infection with L. monocytogenes. At this time point, there are typically no CFU in the bone marrow; however, there are cells producing IFN-␥, and monocytes still in the marrow have undergone inflammatory changes (43) . Likewise, PMN in the marrow of both BALB/c and B6 mice had uniformly upregulated CD11b expression (Fig. 7A ). CD11b is a component of complement receptor 3, and it was previously shown that CD11b increased on the surface of human PMN after activation (44) (45) (46) . However, no significant differences were observed for the ability of CD11b hi PMN to kill L. monocytogenes in vitro compared to cells from uninfected mice (Fig. 7A) . Thus, unprimed cells from the marrow of uninfected mice behaved very similarly to primed cells from the marrow of infected mice.
To assess the ability of activated cells that had already emigrated from the bone marrow, we isolated PMN from infected livers. Collagenase-perfused livers were harvested from both BALB/c and B6 mice at 3.5 days after infection. PMN were gradient enriched, and then kanamycin-resistant L. monocytogenes was added. As shown in Fig.  7B , these cells killed 30 to 40% of the added L. monocytogenes. Together, these results suggest that there are no intrinsic differences in the ability of PMN from susceptible BALB/c or resistant B6 mice to clear L. monocytogenes infection.
DISCUSSION
To begin to address the possibility that susceptibility to listeriosis was determined by an intrinsic defect in PMN function in mice, we developed an in vitro killing assay using PMN enriched from murine bone marrow. We found that murine PMN killed opsonized L. monocytogenes efficiently even without being primed with agents such as (A) CD11b surface expression on sorted PMN from uninfected mice (NI) or mice fed 3 ϫ 10 8 CFU L. monocytogenes SD2000 (2 dpi) was determined. Representative flow cytometry histograms are shown. PMN were incubated with strain SD2001 for 50 min, and the percentage of kanamycin-resistant bacteria killed was determined. Bars indicate means Ϯ SD for 6 technical replicates from one of three independent experiments. (B) BALB/c and B6 female mice were fed 1 ϫ 10 9 CFU L. monocytogenes, and livers were harvested at 3.5 dpi following collagenase perfusion via the portal vein. The enriched nonparenchymal fraction was plated and exposed to strain SD2001 at the indicated MOI for 50 min, and the percentage of kanamycin-resistant bacteria killed was determined. Bars indicate means Ϯ SD for 6 technical replicates from one of two independent experiments. ns, not significant.
PMA or IFN-␥. Furthermore, murine PMN could be sorted and kept in culture for at least 24 h without affecting killing ability. We showed that there was no intrinsic difference in the ability of BALB/c and B6 PMN to kill L. monocytogenes directly ex vivo. However, it is possible that in vivo, there are substances produced in the BALB/c liver that inhibit the function of PMN and thus contribute to the delayed clearance of L. monocytogenes.
In agreement with previous studies using human PMN (33, 47) , we showed that opsonization with naive serum significantly improved the ability of PMN to kill L. monocytogenes. In vitro, complement may be fixed on the surface of L. monocytogenes through the classical or alternative pathway (33, 48) . In vivo, complement is rapidly activated during inflammation and may also be activated by either proteases or acute-phase proteins present during infection (49) . The concentration of specific complement components in the liver during L. monocytogenes infection is unknown, but several studies have found increased expression of complement receptors on activated PMN (44) (45) (46) . In humans, specific antibodies may also be involved in enhancing uptake and killing of L. monocytogenes. Using a rabbit model, Vahidy et al. demonstrated that L. monocytogenes opsonized with immune serum was internalized to a significantly greater extent than bacteria treated with nonimmune serum (50) .
The ROS burst has long been thought of as a primary means by which PMN clear microbes, through oxidative damage to bacterial DNA, peroxidation of membrane lipids, and other mechanisms (37) . ROS might also increase the K ϩ concentration in vacuoles, raising the pH and releasing proteases from an anionic matrix to allow for optimal protease activity (51) . Assembly of the multicomponent NADPH oxidase is triggered by the act of phagocytosis, resulting in targeted release of ROS (52, 53) . However, in this study, only a high MOI induced robust intracellular ROS production in PMN and increased ROS activity did not result in more-efficient killing of L. monocytogenes. PMN from mice genetically unable to make ROS from birth had no defect in killing L. monocytogenes; therefore, nonoxidative killing mechanisms are sufficient. However, in animals capable of triggering an ROS burst, modulation of that response led to reduced bacterial killing. The loss of killing capacity observed after Tempol treatment was likely due to a disruption in the ratio of available oxygen intermediates. Since Tempol has catalase-like activity and also acts as a superoxide dismutase mimetic (40, 41) , it presumably depletes the H 2 O 2 that would normally be acted upon by myeloperoxidase to form hypochlorous acid, the oxidizing agent for DHR 123 (36).
It is not surprising that L. monocytogenes can be resistant to killing by oxidative mechanisms, as the bacteria are known to produce both catalase and superoxide dismutase as protection against host-derived ROS (54) . Previously, stationary-phase L. monocytogenes bacteria were found to be more vulnerable to killing by human PMN than logarithmic-phase bacteria, a result that was attributed to lower catalase production (55) . Furthermore, superoxide dismutase was found to be phosphorylated and thus less active in stationary-phase L. monocytogenes (56) . However, in our study, we found no significant difference in the ability of murine PMN to kill either logarithmic-phase or stationary-phase L. monocytogenes, and both cultures produced similar bubbling reactions in the presence of hydrogen peroxide (M. G. Pitts, unpublished observation). The L. monocytogenes cytolysin listeriolysin O (LLO) was also shown to inhibit the activation of NADPH oxidase in macrophages (57) ; however, the toxin may be rapidly degraded in PMN (58) .
PMN granules contain a variety of proteins and peptides that provide nonoxidative means of killing bacteria, including cathepsin G, elastase, proteinase 3, lactoferrin, and lysozyme (59). Alford et al. showed that purified cathepsin G alone could kill either S. aureus or L. monocytogenes (60) . Since several of these compounds are serine proteases (60, 61), we expected to find at least a partial loss of killing efficiency after pretreatment with DFP, a serine protease inhibitor, but this occurred only in a gp91phox Ϫ/Ϫ background. DFP was previously used to show that serine proteases were important for human PMN to kill Streptococcus pneumoniae (62) , but ROS activity was not monitored in that study, so we cannot make a direct comparison to our results. DFP was also used to inhibit proteolysis of CD43 on human PMN stimulated with opsonized zymosan; in that study, the DFP did not inhibit ROS generation (42) . This suggests that the nature of the phagocytosed particle may determine whether or not DFP impacts the ROS burst.
Circulating PMN are readily obtained from human peripheral blood; however, the cells are easily affected by ex vivo isolation and labeling techniques and are prone to rapid cell death (25, (63) (64) (65) . In contrast, mature PMN harvested from the bone marrow have a longer half-life, can be maintained in culture for at least 24 h (26), and as we showed here, are not affected by manipulations such as cell sorting. A key advantage of using unprimed cells, rather than cells that have already egressed from the bone marrow, is the ability to study how specific inflammatory signals alter the functional properties of the PMN. An important challenge for future work will be to understand how signals in infected tissues such as the liver may affect the function of PMN during infection.
MATERIALS AND METHODS
Bacteria. Mouse-adapted (InlA m -expressing) L. monocytogenes EGDe derivatives SD2000, SD2001 (kanamycin resistant), and SD2710 (constitutive GFP) were used in this study (43, 66) . A freshly streaked colony was inoculated into brain heart infusion (BHI) broth (Difco) and grown with shaking at 37°C overnight (16 h). For in vitro assays, L. monocytogenes cells were washed once with Ca 2ϩ /Mg 2ϩ -free Hanks' balanced salt solution (HBSS; Gibco) and then diluted in the same buffer. For serum pretreatment, autologous mouse serum was added (final concentration, 10%) for 30 min. Pretreatment with serum alone in the absence of PMN had no effect on L. monocytogenes growth (data not shown). Heatinactivated serum was incubated at 55°C for 30 min.
Mice. BALBcBy/J (BALB/c; stock number 001026), C57BL/6J (B6; stock number 000664), and B6.129S-Cybb tm1Din /J (gp91 phoxϪ/Ϫ ; stock number 002365) mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and housed in a specific-pathogen-free facility. Bone marrow was harvested from both male and female animals 8 to 16 weeks old; no significant differences were noted in PMN recovery per gram of weight between male and female mice. Blood was collected from the aorta immediately after euthanasia and transferred to a serum separator tube (BD), followed by centrifugation for 2 min at 20,000 ϫ g. Serum was stored at 4°C for use the same day or at Ϫ80°C for later use. All procedures were approved by the Institutional Animal Care and Use Committee at the University of Kentucky.
Liver nonparenchymal cell preparation. Mice were fed bread contaminated with L. monocytogenes SD2000 as described previously (67, 68) ; control mice were fed phosphate-buffered saline (PBS)-saturated bread pieces. Livers were perfused via the hepatic portal vein with 11 ml of collagenase type IV solution (250 U/ml in HBSS; Worthington), removing blood present in the tissue. The perfused tissue was cut into small pieces, transferred to a 50-ml tube containing DNase (10 U/ml; Worthington) and collagenase type IV (100 U/ml) in 10 ml of RP-5 medium (RPMI 1640 [Life Technologies number 21870], 5% fetal bovine serum [FBS; Gemini], 2.5 mM L-glutamine, 10 mM HEPES, and 0.1 mM ␤2-mercaptoethanol [SigmaAldrich]), and incubated for 35 min with shaking at 37°C. The digested tissue was gently pushed through a mesh screen (number 80 mesh) to create a single-cell suspension. At this point, 1/10 of the volume was removed for determination of CFU burdens. Nonparenchymal cells were enriched by allowing 2 min of settling time followed by centrifugation for 1 min at 50 ϫ g at 4°C. Supernatant was centrifuged at 300 ϫ g at 4°C for 10 min, the pellet was suspended in 30 ml of RPMI 1640, and the prior two steps were repeated. Finally, the pellet was suspended in 1.6 ml cold RPMI 1640 followed by addition of 2.4 ml cold 40% Histodenz (Sigma) in PBS. The suspension was layered under 2 ml of cold RPMI 1640 in 15-ml polyethylene terephthalate (PET) tubes (Corning) that had been precoated with FBS. Samples were centrifuged for 20 min at 4°C at 1,500 ϫ g with no brake. The interface was collected and passed through a filter to remove clumps.
Bone marrow harvest. Marrow was flushed from femurs and tibias with medium containing 2 M EDTA (Gibco) and 25 g/ml gentamicin (Gibco). Cells (two bones per tube) were passed through a sterile mesh filter into a 15-ml PET tube and pelleted by centrifugation at 400 ϫ g. Erythrocytes were lysed by exposure to 0.2% NaCl for 20 s followed by addition of an equal volume of 1.6% NaCl.
Density gradient enrichment of PMN. Following erythrocyte lysis, PMN were enriched as described previously (27) . The bottom layer of cells was recovered and suspended in RP-10 (same as RP-5 but with 10% FBS) or flow cytometry buffer (Ca 2ϩ /Mg 2ϩ -free HBSS, 25 mM HEPES, 5 mM EDTA, 1% FBS).
Flow cytometry. Cells were stained using fluorescently conjugated antibodies specific for the following molecules: Ly6C (HK1.4) and Ly6G (1A-8), purchased from Biolegend; CD11b (M1/70), CD3 (500A2), B220 (RA3-6B2), CD64 (X54-5/7.1), and CD19 (1D3), purchased from eBioscience. Neutrophils were defined as Ly6G hi Ly6C ϩ/Ϫ , monocytes as Ly6G Ϫ Ly6C hi , and B cells as Ly6G Ϫ Ly6C Ϫ CD19 ϩ . The sort gating strategy incorporated live-cell and singlet gates prior to gating on individual markers; sort purities for PMN ranged from 92 to 99%. Cells were sorted into flow cytometry buffer containing 50% FBS and 25 g/ml gentamicin and then washed twice with RP-10 medium. Fluorescence was measured using an LSR II flow cytometer (BD Biosciences) or an iCyt Synergy sorter, and analysis was performed using FlowJo v.10 (Tree Star).
In vitro killing assay. Neutrophils (10 5 /well) were plated in 96-well flat-bottom tissue culture-treated plates in 100 l in RP-10 and incubated at 37°C in 7% CO 2 for 1 h to allow a period of recovery. L. monocytogenes was added at the indicated MOI in a volume of 20 to 40 l to 3 to 6 wells per sample group. In each experiment, a group of wells contained bacteria only (no PMN) to assess growth/survival. The plate was centrifuged at 300 ϫ g for 5 min and then incubated at 37°C in 7% CO 2 . At each time point, the content of each well was transferred to individual microcentrifuge tubes and wells were vigorously washed 3 times with PBS and examined microscopically to ensure that all cells were removed. Serial dilutions of each well were prepared in PBS and plated on BHI agar (Difco). The percentage of L. monocytogenes killed was calculated by dividing the number of CFU from wells with PMN by the mean number of CFU from wells without PMN.
Gentamicin protection assay. Gradient-enriched PMN were plated and exposed to serumopsonized L. monocytogenes as described above. Gentamicin was added at a final concentration of 10 g/ml 10 min later. At indicated time points, the cells were washed once with RP-10, lysed by addition of sterile water, and plated on BHI agar.
Chemotaxis assay. An under-agarose assay was used as described previously by Heit and Kubes (69), with the exception of the following modifications. Ultrapure agarose (1%; Invitrogen) was dissolved in Ca 2ϩ /Mg 2ϩ -free HBSS and diluted with phenol red-free RPMI 1640 containing a final concentration of 2.5% FBS. FBS-coated 60-mm petri dishes were filled with 4.5 ml of the agarose mixture. Three-millimeter holes were cored 2 mm apart using a sterilized template made from a silicone sheet and a hollow punch tool. Either 1 M formylated synthetic peptide (fMIVTLF plus fMIGWII; Bio-Synthesis, Inc.) or 100 nM leukotriene B4 (Cayman Chemical) diluted in Ca 2ϩ /Mg 2ϩ -free HBSS was applied to the center well and allowed to diffuse into the gel prior to addition of gradient-enriched PMN (2 ϫ 10 5 /well) to the outer wells. Dishes were incubated at 37°C in 7% CO 2 for 3 h. Images were acquired in differential interference contrast (DIC) mode with a Nikon A1R confocal microscope, using a 10ϫ air objective with a numerical aperture of 0.45 and the transmitted light detector. Image seize was 4,096 by 4,096 pixels with a resolution of 0.31 m/pixel. The distance traveled was determined using the manual measurement tool in the NIS-Elements software program (Nikon).
Immunofluorescence microscopy. Sorted PMN were plated in RP-10 and rested for 1 h, and then cytochalasin D (Sigma) (20 M in dimethyl sulfoxide [DMSO] ) was added and cells were incubated for 45 min at 37°C in 7% CO 2 . L. monocytogenes SD2710 was added to the wells, and the plate was centrifuged for 5 min at 300 ϫ g, followed by incubation for 5 min at 37°C in 7% CO 2 . Difco Listeria O Antiserum Poly (BD Biosciences) and goat anti-rabbit IgG-Texas Red (Thermo Fisher) were used to perform differential "in/out" staining as described previously (43) . Cells were visualized using a Zeiss Axio Imager.Z1 with a 100ϫ/1.4 NA PlanApo oil immersion objective and analyzed with AxioVision software. Slides were blinded and examined by two different investigators; average values are reported.
Reactive oxygen species. Gradient-enriched PMN were plated in RP-10, rested for 1 h, and then centrifuged at 300 ϫ g and suspended in Ca 2ϩ /Mg 2ϩ -free HBSS. Dihydrorhodamine 123 (DHR; Cayman Chemical number 85100) suspended in DMSO and diluted in HBSS was added to wells (final concentration, 2.5 g/ml) 15 min prior to addition of either L. monocytogenes or 20 nM PMA diluted in HBSS (Sigma catalog number P1585). Plates were centrifuged at 300 ϫ g for 5 min and then incubated at 37°C in 7% CO 2 . To scavenge reactive oxygen intermediates, cells were incubated for 90 min with 50 mM 4-hydroxy Tempo dissolved in HBSS (Tempol, Sigma catalog number 176141). L. monocytogenes was added at the indicated MOI, and the mixture was further incubated for 30 min. DHR was added during the final 15 min of incubation.
Serine protease inhibition. Cells were treated with diisopropylfluorphosphate (DFP; Sigma catalog number D0879), suspended in isopropanol, and diluted in HBSS for 30 min at 37°C in 7% CO 2 . DHR was added to the wells prior to addition of L. monocytogenes. For flow cytometry analysis, cells were washed, stained with fluorescently tagged anti-Ly6G antibody, and fixed in 10% formalin after incubation with bacteria.
Statistical analysis. Statistical analysis was performed using Prism 6 for Macintosh. Unless otherwise indicated, unpaired Student's t tests were performed. P values of Ͻ0.05 were considered significant and are indicated in the figures by asterisks: *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ****, P Ͻ 0.0001.
